Exam (elaborations)
US RAC Practice Exam Questions and Answers
- Course
- Institution
US RAC Practice Exam Questions and Answers
[Show more]
Content preview
US RAC Practice Exam Questions andAnswers
[Q]Which meeting is held with the FDA for the purpose of reaching concurrence on the
key parameters of the investigational plan for a Class III device?
[A] Agreement meeting
[B] Determination meeting
[C] Presubmission meeting
[D] PMA Day-100 meeting - Answers -[A] Agreement meeting
[Q]Which meeting held with the FDA is necessary for an otherwise stalled drug product
development program to proceed?
[A] Type A
[B] Type B
[C] Type C
[D] Type D - Answers -[A] Type A
[Q]Which type of meeting is held with the FDA for a Special Protocol Assessment?
[A] Type A
[B] Type B
[C] Type C
[D] Type D - Answers -[A] Type A
[Q]Within how many days after FDA's receipt of a written request for a meeting should
the following meetings occur: Type A, Type B, Type C
[A] 15, 30, 45
[B] 30, 45, 60
[C] 30, 60, 90
[D] 30, 60, 75 - Answers -[D] 30, 60, 75
[Q]How often does a drug product listing need to occur?
[A] Annually
[B] Every June and December
[C] Quarterly
[D] Once - Answers -[B] Every June and December
[Q]Upon receipt of a complete PMA, how many days does the FDA have to approve or
not approve the PMA?
[A] 90
[B] 120
[C] 150
,[D] 180 - Answers -[D] 180
[Q]What is the one section that is required in an NDA but not in a BLA?
[A] CMC
[B] Clinical data
[C] Field copy certification
[D] Microbiology - Answers -[C] Field copy certification
[Q]What are the possible outcomes to a PMA?
[A] Approval, unacceptable, refusal
[B] Acceptance, pending, rejected
[C] Approval, Approvable, not approvable, denial
[D] Approval letter, complete response letter, refuse to file letter - Answers -[C]
Approval, Approvable, not approvable, denial
[Q]What are the possible outcomes to an NDA?
[A]Approval, unacceptable, refusal
[B]Approval letter, complete response letter, refuse to file letter
[C]Approval, not approvable, denial
[D]Acceptance, pending, rejected - Answers -[B]Approval letter, complete response
letter, refuse to file letter
[Q]What is the approval timeline for a priority NDA versus a standard NDA?
[A] 10 months, 12 months
[B] 6 months, 10 months
[C] 6 months, 12 months
[D] 12 months, 18 months - Answers -[B] 6 months, 10 months
[Q]A new drug is any drug not generally recognized as safe and effective before ____.
[A] 1964
[B] 1948
[C] 1927
[D] 1938 - Answers -[D] 1938
[Q]A 510 (k) is required for ____ Class I devices and ____ Class II devices.
[A] Some, most
[B] All, all
[C] All, most
[D] Most, some - Answers -[A] Some, most
[Q]Which 510 (k) do you file where a guidance document exists that provides
reasonable assurance that the device's safety and effectiveness have been
established?
[A] Traditional
[B] Standard
[C] Abbreviated
, [D] Special - Answers -[C] Abbreviated
[Q]Which 510 (k) do you file where the device modification does not affect its intended
use?
[A] Traditional
[B] Standard
[C] Abbreviated
[D] Special - Answers -[D] Special
[Q]A determination of substantial equivalence to a 510 (k) implies ________ to market
the device, not ________ to market the device.
[A] Approval, clearance
[B] Clearance, approval
[C] Permission, approval
[D] Clearance, notification - Answers -[B] Clearance, approval
[Q]If the FDA requests additional information while reviewing a 510 (k) submission, you
have ___ days to respond.
[A] 30
[B] 60
[C] 90
[D] 180 - Answers -[D] 180
[Q]Which of the following are exempt from premarket notification?
[A] Custom devices
[B] Special devices
[C] Restricted devices
[D] None of the above - Answers -[A] Custom devices
[Q]Form FDA ____, Blood Establishment Registration and Product Listing, is used for
submission of registration and product listing information to the FDA.
[A] 4030
[B] 2830
[C] 3356
[D] 1170 - Answers -[B] 2830
[Q]Completion of Form FDA ____ is required for all establishments engaged in the
recovery, processing, storage, labeling, packaging, or distribution of any Human Cells,
Tissues, and Cellular and Tissue-Based Products (HCT/Ps), or the screening or testing
of a cell or tissue donor.
[A] 4030
[B] 2830
[C] 3356
[D] 1170 - Answers -[C] 3356
[Q]A PMA has a __ day administrative review period and a __ day filing review period.
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller millyphilip. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $13.49. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67096 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now